Upgrade to SI Premium - Free Trial

Guggenheim Reiterates Buy Rating on Neurogene (NGNE)

April 28, 2026 6:10 AM
Guggenheim analyst Debjit Chattopadhyay reiterated a Buy rating and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments